{
    "clinical_study": {
        "@rank": "122807", 
        "arm_group": {
            "arm_group_label": "Indicated for a VVI(R) pacemaker"
        }, 
        "brief_summary": {
            "textblock": "The objective of the study is to confirm clinical performance and safety of the Nanostim\n      leadless cardiac pacemaker system within its intended use and according to its instructions\n      for use."
        }, 
        "brief_title": "The LEADLESS Observational Study", 
        "completion_date": {
            "#text": "March 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Indications for VVI(R) Pacemaker", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject must have one of the following clinical indications: Chronic atrial\n             fibrillation  with 2 or 3\u00b0 AV or bifascicular bundle branch block (BBB block) ; or\n             Normal sinus rhythm with 2\u00ba or 3\u00b0 AV or BBB block  and a low level of physical\n             activity or short expected lifespan (but at least one year); or Sinus bradycardia\n             with infrequent pauses or unexplained syncope with EP findings; and\n\n          -  Subject \u226518 years of age; and\n\n          -  Subject has life expectancy of at least one year; and\n\n          -  Subject is not enrolled in another clinical investigation with a treatment arm or\n             that could confound the results of this study; and\n\n          -  Subject is willing to comply with clinical investigation procedures and agrees to\n             return for all required follow-up visits, tests, and exams; and\n\n          -  Subject has been informed of the nature of the study, agrees to its provisions and\n             has provided written informed consent, approved by the EC; and\n\n          -  Subject is not pregnant and does not plan on getting pregnant during the course of\n             the study.\n\n        Exclusion Criteria:\n\n          -  Known pacemaker syndrome, have retrograde VA conduction or suffer a drop in arterial\n             blood pressure with the onset of ventricular pacing; or\n\n          -  Hypersensitivity to < 1 mg of dexamethasone sodium phosphate; or\n\n          -  Mechanical tricuspid valve prosthesis; or\n\n          -  Pre-existing pulmonary arterial (PA) hypertension or significant\n             physiologically-impairing lung disease; or\n\n          -  Pre-existing ventricular pacing or defibrillation leads; or\n\n          -  Current implantation of either conventional or subcutaneous implantable cardioverter\n             defibrillator (ICD) or cardiac resynchronization therapy (CRT); or\n\n          -  Presence of implanted vena cava filter; or\n\n          -  Evidence of thrombosis in one of the veins used for access during the procedure; or\n\n          -  Presence of implanted leadless cardiac pacemaker"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects who are at least 18 years old and who are indicated for a VVI(R) pacemaker"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02051972", 
            "org_study_id": "LCP005"
        }, 
        "intervention": {
            "arm_group_label": "Indicated for a VVI(R) pacemaker", 
            "intervention_name": "Implanted with a Nanostim leadless pacemaker system", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 30, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Prague", 
                        "country": "Czech Republic", 
                        "zip": "150 30"
                    }, 
                    "name": "Na Homolce Hospital"
                }, 
                "investigator": {
                    "last_name": "Peter Neuzil, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bad Nauheim", 
                        "country": "Germany", 
                        "zip": "61231"
                    }, 
                    "name": "Kerckhoff Klinik"
                }, 
                "investigator": {
                    "last_name": "Johannes Sperzel, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1105 AZ"
                    }, 
                    "name": "AMC"
                }, 
                "investigator": {
                    "last_name": "Reinoud Knops, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Badajoz", 
                        "country": "Spain", 
                        "zip": "6010"
                    }, 
                    "name": "Hospital Infanta Cristina"
                }, 
                "investigator": {
                    "last_name": "Garcia Guerrero, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28046"
                    }, 
                    "name": "Hospital Universitario la Paz"
                }, 
                "investigator": {
                    "last_name": "Jorge Silvestre, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Czech Republic", 
                "Germany", 
                "Netherlands", 
                "Spain"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Nanostim Study for a Leadless Cardiac Pacemaker System", 
        "other_outcome": {
            "description": "A complication is defined as a serious adverse device effect", 
            "measure": "Complication-free rate", 
            "safety_issue": "Yes", 
            "time_frame": "5 years"
        }, 
        "overall_contact": {
            "email": "aoza@sjm.com", 
            "last_name": "Asish Oza", 
            "phone": "+1 818 493 3648"
        }, 
        "overall_contact_backup": {
            "email": "pducloux@sjm.com", 
            "last_name": "Pascale Ducloux", 
            "phone": "+32 2 774 67 09"
        }, 
        "overall_official": {
            "affiliation": "Kerckhoff Klinick GmbH, Bad Nauheim, Germany", 
            "last_name": "Johannes Sperzel, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Austria : Federal Ministry for Labour, Health, and Social Affairs", 
                "Austria: Austrian Medicines and Medical Devices Agency", 
                "Czech Republic: Ethics Committee", 
                "France: Institutional Ethical Committee", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "Germany: Ethics Commission", 
                "Ireland: Research Ethics Committee", 
                "Italy: Ethics Committee", 
                "Spain: Ethics Committee", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Switzerland: Ethikkommission", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A complication is defined as a serious adverse device effect", 
            "measure": "Complication free-rate", 
            "safety_issue": "Yes", 
            "time_frame": "90 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02051972"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "A complication is defined as a serious adverse device effect", 
            "measure": "Incidence of observed complication rate", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "source": "St. Jude Medical", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "St. Jude Medical", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}